Rockville, MD, USA, Aug. 22, 2017 -- The Regulatory Affairs Professionals Society (RAPS) has revealed the names of the six outstanding senior regulatory professionals who will join the elite group of RAPS Fellows this year. They will be recognized during the opening plenary session of the RAPS Regulatory Convergence conference at the Gaylord National Resort and Convention Center at National Harbor on the Washington, DC, waterfront 9–12 September. The Convergence is the largest annual gathering of the global regulatory profession.
“To be selected as a RAPS Fellow is an honor reserved for senior regulatory professionals who have continuously advanced the profession and served as leaders throughout their careers,” said Fellows Selection Committee Chair Nancy Gertlar, president of Crossroads Consulting. “These six distinguished experts will serve as important resources for knowledge and guidance to RAPS and to the entire global regulatory community.”
|
||||||
The 2017 RAPS Fellows are:
- Kaia Agarwal, MSc, FRAPS, president, Regulatory Compass LLC
- Mark De Rosch, PhD, FRAPS, senior vice president, regulatory affairs, quality assurance, and CMC, Akebia Therapeutics
- Susan Hamann, MS, RAC, MT (ASCP), FRAPS, president, Hamann QR Consulting
- Joel Kent, RAC, FRAPS, manager, regulatory affairs, GE Healthcare
- Darin Oppenheimer, PhD, RAC, FRAPS, executive director, head, Drug Device Center of Excellence, Merck
- Joanne Palmisano, MD, FACP, FRAPS, vice president, regulatory affairs, Boehringer Ingelheim Pharmaceuticals Inc.
Reporters, bloggers and other members of the media who wish to cover all or part of the RAPS Regulatory Convergence should contact Zachary Brousseau, senior manager, communications, RAPS, at [email protected] or +1 301 770 2920, ext. 245. On-site registration also will be available for media with valid press credentials or a letter from an assigning editor.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with chapters and affiliates worldwide. www.RAPS.org
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/fda7a9d3-5c26-4e4d-a42c-19b4f1f9c534
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e893afd9-000a-4745-b8c3-b9874c5d25b4
Zachary Brousseau Regulatory Affairs Professionals Society (RAPS) 301 770 2920, ext. 245 [email protected]


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



